drugset

drugset / Trial / NCT07371728

Effect of Aprepitant on Post-operative Nausea and Vomiting in Otologic Surgery

NCT07371728 ↗

Phase 4 Not yet recruiting 100 enrolled Sir Mortimer B. Davis - Jewish General Hospital

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This project is being carried out to study the use of a medication to reduce nausea and vomiting after ear surgery.

Timeline

Start: 2026-06-01
Primary completion: 2027-06-01
Completion: 2028-06-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Aprepitant	Other / unclassified	80 mg	Oral

Indications